| Advanced Health And Rehab Of Union County | |
| 1700 East Short Hillsboro, El Dorado, Arkansas 71730 | |
| (870) 862-5124 | |
| Name | Advanced Health And Rehab Of Union County |
|---|---|
| Location | 1700 East Short Hillsboro, El Dorado, Arkansas |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 122 |
| Occupancy Rate | 42.21% |
| Medicare ID (CCN) | 045275 |
| Legal Business Name | Phg El Dorado Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1043805740 |
| Organization Name | ADVANCED NURSING AND REHAB OF ELDORADO LLC |
| Address | 1700 E Short Hillsboro St, El Dorado, AR 71730 |
| Phone Number | 870-862-5124 |
News Archive
A new study published online in the journal eBioMedicine on October 15, 2019, describes the use of an orally ingested agent called 5-aminolevulinic acid (5-ALA) to confirm the diagnosis of the aggressive brain tumor called glioma.
LUNGevity President Andrea Ferris, a member of the Stand Up to Cancer Lung Cancer Dream Team, presented the team's newly launched website, a patient-centric resource that enables users to be active, informed participants in their diagnosis and treatment, at a poster session at the 2016 Stand Up to Cancer (SU2C) Scientific Summit.
Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair® (Pressair™ in the USA).
A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal and Max von Kleist of Freie Universität Berlin and colleagues, could help streamline development of new PrEP treatments.
A study by University at Buffalo sociologists has found that the portrayal of women in the popular media over the last several decades has become increasingly sexualized, even "pornified." The same is not true of the portrayal of men.
› Verified 2 days ago
| NPI Number | 1386065316 |
| Organization Name | CHARLOTTE SPRINGS, LLC |
| Address | 1700 E Short Hillsboro St, El Dorado, AR 71730 |
| Phone Number | 870-862-5124 |
News Archive
A new study published online in the journal eBioMedicine on October 15, 2019, describes the use of an orally ingested agent called 5-aminolevulinic acid (5-ALA) to confirm the diagnosis of the aggressive brain tumor called glioma.
LUNGevity President Andrea Ferris, a member of the Stand Up to Cancer Lung Cancer Dream Team, presented the team's newly launched website, a patient-centric resource that enables users to be active, informed participants in their diagnosis and treatment, at a poster session at the 2016 Stand Up to Cancer (SU2C) Scientific Summit.
Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair® (Pressair™ in the USA).
A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal and Max von Kleist of Freie Universität Berlin and colleagues, could help streamline development of new PrEP treatments.
A study by University at Buffalo sociologists has found that the portrayal of women in the popular media over the last several decades has become increasingly sexualized, even "pornified." The same is not true of the portrayal of men.
› Verified 2 days ago
| NPI Number | 1447670351 |
| Organization Name | ELLA MANOR LLC |
| Address | 1700 E Short Hillsboro St, El Dorado, AR 71730 |
| Phone Number | 870-862-5124 |
News Archive
A new study published online in the journal eBioMedicine on October 15, 2019, describes the use of an orally ingested agent called 5-aminolevulinic acid (5-ALA) to confirm the diagnosis of the aggressive brain tumor called glioma.
LUNGevity President Andrea Ferris, a member of the Stand Up to Cancer Lung Cancer Dream Team, presented the team's newly launched website, a patient-centric resource that enables users to be active, informed participants in their diagnosis and treatment, at a poster session at the 2016 Stand Up to Cancer (SU2C) Scientific Summit.
Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair® (Pressair™ in the USA).
A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal and Max von Kleist of Freie Universität Berlin and colleagues, could help streamline development of new PrEP treatments.
A study by University at Buffalo sociologists has found that the portrayal of women in the popular media over the last several decades has become increasingly sexualized, even "pornified." The same is not true of the portrayal of men.
› Verified 2 days ago
| NPI Number | 1568946937 |
| Organization Name | PHG EL DORADO LLC |
| Address | 1700 E Short Hillsboro St, El Dorado, AR 71730 |
| Phone Number | 870-862-5124 |
News Archive
A new study published online in the journal eBioMedicine on October 15, 2019, describes the use of an orally ingested agent called 5-aminolevulinic acid (5-ALA) to confirm the diagnosis of the aggressive brain tumor called glioma.
LUNGevity President Andrea Ferris, a member of the Stand Up to Cancer Lung Cancer Dream Team, presented the team's newly launched website, a patient-centric resource that enables users to be active, informed participants in their diagnosis and treatment, at a poster session at the 2016 Stand Up to Cancer (SU2C) Scientific Summit.
Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair® (Pressair™ in the USA).
A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal and Max von Kleist of Freie Universität Berlin and colleagues, could help streamline development of new PrEP treatments.
A study by University at Buffalo sociologists has found that the portrayal of women in the popular media over the last several decades has become increasingly sexualized, even "pornified." The same is not true of the portrayal of men.
› Verified 2 days ago
| NPI Number | 1700208014 |
| Organization Name | HILLSBORO MANOR NURSING HOME, INC. |
| Address | 1700 E Short Hillsboro St, El Dorado, AR 71730 |
| Phone Number | 870-862-5124 |
News Archive
A new study published online in the journal eBioMedicine on October 15, 2019, describes the use of an orally ingested agent called 5-aminolevulinic acid (5-ALA) to confirm the diagnosis of the aggressive brain tumor called glioma.
LUNGevity President Andrea Ferris, a member of the Stand Up to Cancer Lung Cancer Dream Team, presented the team's newly launched website, a patient-centric resource that enables users to be active, informed participants in their diagnosis and treatment, at a poster session at the 2016 Stand Up to Cancer (SU2C) Scientific Summit.
Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair® (Pressair™ in the USA).
A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal and Max von Kleist of Freie Universität Berlin and colleagues, could help streamline development of new PrEP treatments.
A study by University at Buffalo sociologists has found that the portrayal of women in the popular media over the last several decades has become increasingly sexualized, even "pornified." The same is not true of the portrayal of men.
› Verified 2 days ago
| NPI Number | 1831510866 |
| Organization Name | GRACE POINT, LLC |
| Address | 1700 E Short Hillsboro St, El Dorado, AR 71730 |
| Phone Number | 870-862-5124 |
News Archive
A new study published online in the journal eBioMedicine on October 15, 2019, describes the use of an orally ingested agent called 5-aminolevulinic acid (5-ALA) to confirm the diagnosis of the aggressive brain tumor called glioma.
LUNGevity President Andrea Ferris, a member of the Stand Up to Cancer Lung Cancer Dream Team, presented the team's newly launched website, a patient-centric resource that enables users to be active, informed participants in their diagnosis and treatment, at a poster session at the 2016 Stand Up to Cancer (SU2C) Scientific Summit.
Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair® (Pressair™ in the USA).
A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal and Max von Kleist of Freie Universität Berlin and colleagues, could help streamline development of new PrEP treatments.
A study by University at Buffalo sociologists has found that the portrayal of women in the popular media over the last several decades has become increasingly sexualized, even "pornified." The same is not true of the portrayal of men.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new study published online in the journal eBioMedicine on October 15, 2019, describes the use of an orally ingested agent called 5-aminolevulinic acid (5-ALA) to confirm the diagnosis of the aggressive brain tumor called glioma.
LUNGevity President Andrea Ferris, a member of the Stand Up to Cancer Lung Cancer Dream Team, presented the team's newly launched website, a patient-centric resource that enables users to be active, informed participants in their diagnosis and treatment, at a poster session at the 2016 Stand Up to Cancer (SU2C) Scientific Summit.
Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair® (Pressair™ in the USA).
A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal and Max von Kleist of Freie Universität Berlin and colleagues, could help streamline development of new PrEP treatments.
A study by University at Buffalo sociologists has found that the portrayal of women in the popular media over the last several decades has become increasingly sexualized, even "pornified." The same is not true of the portrayal of men.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $153710 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 20.99 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 0.51 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 32.58 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.94 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.73 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.76 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.42 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 8.7 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 26.34 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.63 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.26 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.72 | 95.98 |